-+ 0.00%
-+ 0.00%
-+ 0.00%

LONGEVERON INC: PHASE 2B CLINICAL TRIAL IN HYPOPLASTIC LEFT HEART SYNDROME ANTICIPATED IN Q3 OF 2026

Reuters·02/13/2026 21:30:00

Please log in to view news